Gunasekaran et al., 2012 - Google Patents
Differential regulation of embryonic and adult β cell replicationGunasekaran et al., 2012
View PDF- Document ID
- 18152801756218709804
- Author
- Gunasekaran U
- Hudgens C
- Wright B
- Maulis M
- Gannon M
- Publication year
- Publication venue
- Cell cycle
External Links
Snippet
Diabetes results from an inadequate functional β cell mass, either due to autoimmune destruction (Type 1 diabetes) or insulin resistance combined with β cell failure (Type 2 diabetes). Strategies to enhance β cell regeneration or increase cell proliferation could …
- 210000000227 basophil cell of anterior lobe of hypophysis 0 title abstract description 292
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
- C12N5/0602—Vertebrate cells
- C12N5/0618—Cells of the nervous system
- C12N5/0619—Neurons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Gunasekaran et al. | Differential regulation of embryonic and adult β cell replication | |
| Sharma et al. | Living dangerously: protective and harmful ER stress responses in pancreatic β-cells | |
| Cheng et al. | Fasting-mimicking diet promotes Ngn3-driven β-cell regeneration to reverse diabetes | |
| Templeman et al. | Suppression of hyperinsulinaemia in growing female mice provides long-term protection against obesity | |
| Kushner | The role of aging upon β cell turnover | |
| Dai et al. | Stress-impaired transcription factor expression and insulin secretion in transplanted human islets | |
| Alejandro et al. | Maternal diet–induced microRNAs and mTOR underlie β cell dysfunction in offspring | |
| Rieck et al. | Expansion of β-cell mass in response to pregnancy | |
| Accili et al. | When β‐cells fail: lessons from dedifferentiation | |
| Stiles et al. | Selective deletion of Pten in pancreatic β cells leads to increased islet mass and resistance to STZ-induced diabetes | |
| Jia et al. | Characterization of cold‐induced remodelling reveals depot‐specific differences across and within brown and white adipose tissues in mice | |
| Mezza et al. | The regulation of pre-and post-maturational plasticity of mammalian islet cell mass | |
| Shirakawa et al. | Glucokinase activation ameliorates ER stress–induced apoptosis in pancreatic β-cells | |
| Plaisance et al. | Role of microRNAs in islet beta‐cell compensation and failure during diabetes | |
| Berger et al. | Gαi/o-coupled receptor signaling restricts pancreatic β-cell expansion | |
| Spaeth et al. | The FOXP1, FOXP2 and FOXP4 transcription factors are required for islet alpha cell proliferation and function in mice | |
| Rachdi et al. | L-leucine alters pancreatic β-cell differentiation and function via the mTor signaling pathway | |
| Tian et al. | Comparison of exendin‐4 on beta‐cell replication in mouse and human islet grafts | |
| Ogata et al. | Promotion of β-cell differentiation by conophylline in fetal and neonatal rat pancreas | |
| Mellado-Gil et al. | Islet β‐Cell Mass Preservation and Regeneration in Diabetes Mellitus: Four Factors with Potential Therapeutic Interest | |
| Kawamori et al. | GLP-1 signalling compensates for impaired insulin signalling in regulating beta cell proliferation in βIRKO mice | |
| Viengchareun et al. | Prolactin receptor signaling is essential for perinatal brown adipocyte function: a role for insulin-like growth factor-2 | |
| Tarabra et al. | A Simple Matter of Life and Death—The Trials of Postnatal Beta‐Cell Mass Regulation | |
| Quesada-Candela et al. | Morphological and functional adaptations of pancreatic alpha-cells during late pregnancy in the mouse | |
| Eldor et al. | Inhibition of nuclear factor-κB activation in pancreatic β-cells has a protective effect on allogeneic pancreatic islet graft survival |